FRIDAY, April 25, 2025 (HealthDay News) -- On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation of a ...

Moderna had designs on releasing a combined influenza and covid-19 vaccine after some promising trials, but this week the ...

In 2023, Moderna started a phase 1/2 study of an experimental pandemic influenza vaccines collectively known as mRNA-1018, which are designed to provide protection against H5 and H7 avian ...

Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu ...

Moderna filed for FDA approval of its mRNA-1083 combination shot last year. The submission put the biotech on track to win ...

Moderna has withdrawn the Biologics License Application (BLA) for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after ...

Avian influenza A(H5N1), commonly known as bird ... are stressing that the risk to the general public remains low. Moderna is currently in the very early stages of testing a bird flu vaccine ...